Profile
Sector:
HealthcareIndustry:
Medical DevicesCountry:
United StatesIPO:
31 May 2018Website:
http://www.envveno.comNext earnings report:
31 July 2024Last dividends:
N/ANext dividends:
N/APrice
regular market | Fri, 28 Jun 2024 20:00:01 GMTDividend
Analysts recommendations
Institutional Ownership
What type of business is enVVeno Medical?
enVVeno Medical Corporation, a medical device company, focuses on the development of various bioprosthetic tissue-based solutions to enhance the standard of care in the treatment of venous diseases. The company's lead product is the VenoValve, a surgical implant being developed for the treatment of severe deep venous chronic venous insufficiency. Its VenoValve is implanted in the femoral vein and acts as a one-way valve to help restore proper blood flow in the leg. The company was formerly known as Hancock Jaffe Laboratories, Inc. and changed its name to enVVeno Medical Corporation in October 2021. enVVeno Medical Corporation was incorporated in 1999 and is based in Irvine, California.
What sector is enVVeno Medical in?
enVVeno Medical is in the Healthcare sector
What industry is enVVeno Medical in?
enVVeno Medical is in the Medical Devices industry
What country is enVVeno Medical from?
enVVeno Medical is headquartered in United States
When did enVVeno Medical go public?
enVVeno Medical initial public offering (IPO) was on 31 May 2018
What is enVVeno Medical website?
https://www.envveno.com
Is enVVeno Medical in the S&P 500?
No, enVVeno Medical is not included in the S&P 500 index
Is enVVeno Medical in the NASDAQ 100?
No, enVVeno Medical is not included in the NASDAQ 100 index
Is enVVeno Medical in the Dow Jones?
No, enVVeno Medical is not included in the Dow Jones index
When does enVVeno Medical report earnings?
The next expected earnings date for enVVeno Medical is 31 July 2024